| Product Code: ETC10416462 | Publication Date: Apr 2025 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Bhawna Singh | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
The India relapsing remitting multiple sclerosis market import shipment experienced a remarkable growth trend from 2020 to 2024, reflected in a high CAGR of 100.6%. Notably, the market sustained strong momentum with a growth rate of 42.5% from 2023 to 2024, indicating a robust expansion phase during this period.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 India Relapsing Remitting Multiple Sclerosis Market Overview |
3.1 India Country Macro Economic Indicators |
3.2 India Relapsing Remitting Multiple Sclerosis Market Revenues & Volume, 2021 & 2031F |
3.3 India Relapsing Remitting Multiple Sclerosis Market - Industry Life Cycle |
3.4 India Relapsing Remitting Multiple Sclerosis Market - Porter's Five Forces |
3.5 India Relapsing Remitting Multiple Sclerosis Market Revenues & Volume Share, By Drug Type, 2021 & 2031F |
3.6 India Relapsing Remitting Multiple Sclerosis Market Revenues & Volume Share, By Mechanism of Action, 2021 & 2031F |
3.7 India Relapsing Remitting Multiple Sclerosis Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.8 India Relapsing Remitting Multiple Sclerosis Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 India Relapsing Remitting Multiple Sclerosis Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about multiple sclerosis and its treatment options among healthcare professionals and patients. |
4.2.2 Growing research and development activities focusing on new and more effective therapies for relapsing-remitting multiple sclerosis. |
4.2.3 Rising healthcare expenditure and improving access to advanced medical treatments in India. |
4.3 Market Restraints |
4.3.1 Limited availability and affordability of advanced therapies for relapsing-remitting multiple sclerosis in the Indian market. |
4.3.2 Lack of skilled healthcare professionals specialized in treating multiple sclerosis, leading to delayed or incorrect diagnosis. |
4.3.3 Regulatory hurdles and challenges related to drug approvals and market access for new treatments. |
5 India Relapsing Remitting Multiple Sclerosis Market Trends |
6 India Relapsing Remitting Multiple Sclerosis Market, By Types |
6.1 India Relapsing Remitting Multiple Sclerosis Market, By Drug Type |
6.1.1 Overview and Analysis |
6.1.2 India Relapsing Remitting Multiple Sclerosis Market Revenues & Volume, By Drug Type, 2021 - 2031F |
6.1.3 India Relapsing Remitting Multiple Sclerosis Market Revenues & Volume, By Immunomodulators, 2021 - 2031F |
6.1.4 India Relapsing Remitting Multiple Sclerosis Market Revenues & Volume, By Monoclonal Antibodies, 2021 - 2031F |
6.1.5 India Relapsing Remitting Multiple Sclerosis Market Revenues & Volume, By Interferons, 2021 - 2031F |
6.1.6 India Relapsing Remitting Multiple Sclerosis Market Revenues & Volume, By S1P Receptor Modulators, 2021 - 2031F |
6.2 India Relapsing Remitting Multiple Sclerosis Market, By Mechanism of Action |
6.2.1 Overview and Analysis |
6.2.2 India Relapsing Remitting Multiple Sclerosis Market Revenues & Volume, By T-Cell Suppression, 2021 - 2031F |
6.2.3 India Relapsing Remitting Multiple Sclerosis Market Revenues & Volume, By B-Cell Targeting, 2021 - 2031F |
6.2.4 India Relapsing Remitting Multiple Sclerosis Market Revenues & Volume, By Cytokine Regulation, 2021 - 2031F |
6.2.5 India Relapsing Remitting Multiple Sclerosis Market Revenues & Volume, By Immune Cell Migration, 2021 - 2031F |
6.3 India Relapsing Remitting Multiple Sclerosis Market, By Route of Administration |
6.3.1 Overview and Analysis |
6.3.2 India Relapsing Remitting Multiple Sclerosis Market Revenues & Volume, By Oral, Injectable, 2021 - 2031F |
6.3.3 India Relapsing Remitting Multiple Sclerosis Market Revenues & Volume, By IV Infusion, 2021 - 2031F |
6.3.4 India Relapsing Remitting Multiple Sclerosis Market Revenues & Volume, By Subcutaneous, Intramuscular, 2021 - 2031F |
6.3.5 India Relapsing Remitting Multiple Sclerosis Market Revenues & Volume, By Oral, 2021 - 2031F |
6.4 India Relapsing Remitting Multiple Sclerosis Market, By End User |
6.4.1 Overview and Analysis |
6.4.2 India Relapsing Remitting Multiple Sclerosis Market Revenues & Volume, By Hospitals, Clinics, 2021 - 2031F |
6.4.3 India Relapsing Remitting Multiple Sclerosis Market Revenues & Volume, By Specialty Centers, 2021 - 2031F |
6.4.4 India Relapsing Remitting Multiple Sclerosis Market Revenues & Volume, By Homecare, Clinics, 2021 - 2031F |
6.4.5 India Relapsing Remitting Multiple Sclerosis Market Revenues & Volume, By Neurology Centers, 2021 - 2031F |
6.5.2 India Relapsing Remitting Multiple Sclerosis Market Revenues & Volume, By Distribution Channel, 2021 - 2031F |
6.5.3 India Relapsing Remitting Multiple Sclerosis Market Revenues & Volume, By Retail Pharmacies, Online Pharmacies, 2021 - 2031F |
6.5.4 India Relapsing Remitting Multiple Sclerosis Market Revenues & Volume, By Specialty Pharmacies, Hospital Pharmacies, 2021 - 2031F |
6.5.5 India Relapsing Remitting Multiple Sclerosis Market Revenues & Volume, By Online Drug Stores, 2021 - 2031F |
7 India Relapsing Remitting Multiple Sclerosis Market Import-Export Trade Statistics |
7.1 India Relapsing Remitting Multiple Sclerosis Market Export to Major Countries |
7.2 India Relapsing Remitting Multiple Sclerosis Market Imports from Major Countries |
8 India Relapsing Remitting Multiple Sclerosis Market Key Performance Indicators |
8.1 Patient adherence rate to prescribed treatment plans. |
8.2 Number of clinical trials conducted for new therapies in the Indian market. |
8.3 Percentage of healthcare providers trained in multiple sclerosis diagnosis and treatment protocols. |
9 India Relapsing Remitting Multiple Sclerosis Market - Opportunity Assessment |
9.1 India Relapsing Remitting Multiple Sclerosis Market Opportunity Assessment, By Drug Type, 2021 & 2031F |
9.2 India Relapsing Remitting Multiple Sclerosis Market Opportunity Assessment, By Mechanism of Action, 2021 & 2031F |
9.3 India Relapsing Remitting Multiple Sclerosis Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.4 India Relapsing Remitting Multiple Sclerosis Market Opportunity Assessment, By End User, 2021 & 2031F |
10 India Relapsing Remitting Multiple Sclerosis Market - Competitive Landscape |
10.1 India Relapsing Remitting Multiple Sclerosis Market Revenue Share, By Companies, 2024 |
10.2 India Relapsing Remitting Multiple Sclerosis Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here